AllQuantitative Report
logoArgusDecember 02, 2021

HRMY: Lowering target price to $41.00

Symbols
HRMY
Sector(s)
Healthcare
Rating
Current Price
$28.93
Price Target
Earnings Estimate
Summary

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing innovative therapies for patients living with r

Upgrade to begin using premium research reports and get so much more.

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Upgrade